Skip to main content
Alisertib shows promising antitumor activity with or without fulvestrant in endocrine-resistant metastatic BC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Alisertib shows promising antitumor activity with or without fulvestrant in endocrine-resistant metastatic BC
User login
Username
Password
Reset your password
Concept
Lead
score
Advanced and Metastatic Breast Cancer
1
1
HER2-Negative Breast Cancer
0
1
Breast Cancer
0
0.62
Breast
0
0.56
Cancer
0
0.56
Epidermal Growth Factor Receptor
0
0.39
Genomic Medicine
0
0.39
Specialty
Lead
score
Hematology-Oncology
1
1
Ob/Gyn & Women's Health
0
1
Pharmacist
0
0.85
Edit Tags